Twenty patients with degenerative disk disease were fitted with a Nubac device and monitored for two years
MARQUETTE -- After years of development and research, studies at Pioneer Surgical in Marquette have reached a new level.
Recently, the clinical results of a two-year study on the NuBac Nucleus Replacement device were presented at the International Society for the Advancement of Spine Surgery meeting in New Orleans. In the study, 20 patients with degenerative disk disease were fitted with a NuBac device and monitored for two years.
And Pioneer Surgical says this device provides many benefits to the patient.
It's preserving the motion. It's the only device where it doesn't result in fusing the two vertebrae together. This allows the same motion that they've had previously," said Fred J. Taccolini, Compliance Officer.
Nubac is the first nucleus replacement device to gain FDA pivotal study approval. They've already started the next step, which will be to put the device in 400 patients and monitor them for a two-year period.
TV Station Profiles & Public Inspection Files forWLUC